| Literature DB >> 36045256 |
Sevgi Deniz Doğan1, Sevban Arslan2.
Abstract
PURPOSE: This study was conducted as a randomized controlled trial to determine the effects of e-mobile training and consultancy services on self-care agency, body image, and quality of life in patients undergoing bariatric surgery.Entities:
Keywords: Bariatric surgery; Consultation; Nursing, Mobile application; Patient education
Year: 2022 PMID: 36045256 PMCID: PMC9433521 DOI: 10.1007/s11695-022-06255-x
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 3.479
Fig. 1CONSORT flow diagram
Comparison of descriptive characteristics of the patients (N = 51)
| Experimental group ( | Control group ( | Test | |||
|---|---|---|---|---|---|
| Median [min–max] | Median [min–max] | ||||
| Age | 37.73 ± 12.97 | 36.5 [19.0–66.0] | 39.88 ± 11.88 | 42.0 [20.0–66.0] | |
| BMI (kg/m2) | 41.40 ± 3.62 | 41.2 [35.4–48.7] | 44.54 ± 5.34 | 42.7 [37.4–54.9] | |
| Sex | |||||
Male Female | 6 20 | 23.1 76.9 | 5 20 | 20.0 80.0 | |
| Education level | |||||
Primary school High school University | 9 10 7 | 34.6 38.5 26.9 | 9 9 7 | 36.0 36.0 28.0 | |
| Working status | |||||
Yes No | 11 15 | 42.3 57.7 | 10 15 | 40.0 60.0 | |
| Economical situation | |||||
Income less than expenses Income equal to expenses | 9 17 | 34.6 65.4 | 10 15 | 40.0 60.0 | |
| Marital status | |||||
Married Single | 18 8 | 69.2 30.8 | 14 11 | 56.0 44.0 | |
| Presence of child | |||||
Yes No | 19 7 | 73.1 26.9 | 18 7 | 72.0 28.0 | |
| Chronic disease | |||||
Yes No | 12 14 | 46.2 53.8 | 9 16 | 36.0 64.0 | |
| Surgery experience | |||||
Yes No | 17 9 | 65.4 34.6 | 16 9 | 64.0 36.0 | |
| Obesity history | |||||
< 10 years > 10 years | 3 23 | 11.5 88.5 | 2 23 | 8.0 92.0 | |
| Bariatric surgery method | |||||
Gastric bypass Sleeve gastrectomy | 18 8 | 69.2 30.8 | 18 7 | 72.0 28.0 | |
aIndependent sample-t, bMann-Whitney U, cPearson-χ2
Comparison of Self-Care Agency Scale of patients during different stages
| Self-Care Agency Scale | Experimental group ( | Control group ( | Test | ||
|---|---|---|---|---|---|
| Median [min–max] | Median [min–max] | ||||
| Preoperative(0) | 93.92 ± 16.23 | 96.5 [56.0–128.0] | 90.64 ± 26.13 | 89.0 [11.0–130.0] | |
| 1st mount(1) | 102.69 ± 11.32 | 104.0 [84.0–122.0] | 97.84 ± 17.83 | 99.0 [69.0–140.0] | |
| 2nd month(2) | 104.54 ± 9.29 | 106.5 [81.0–120.0] | 98.08 ± 14.31 | 98.0 [70.0–126.0] | |
| 3rd month(3) | 104.35 ± 9.14 | 104.5 [80.0–117.0] | 100.08 ± 18.53 | 101 [31.0–126.0] | |
| Test | [0–1,2,3] | [0–3] | |||
*α<0.05
aIndependent sample-t, bMann-Whitney U, crepeated measures, dFriedman
Comparison of body image scores of patients during different stages
| Body image scale | Experimental group ( | Control group ( | Test | ||
|---|---|---|---|---|---|
| Median | Median | ||||
| Preoperative (0) | 128.19 ± 24.68 | 125.5 [81.0–181.0] | 131.24 ± 29.39 | 121.0 [94.0–196.0] | |
| 1st mount(1) | 135.58 ± 25.88 | 128.0 [97.0–188.0] | 128.92 ± 25.62 | 120.0 [98.0–185.0] | |
| 2nd month(2) | 142.96 ± 25.42 | 138.5 [106.0–198.0] | 129.84 ± 31.13 | 126.0 [44.0–188.0] | |
| 3rd month(3) | 148.58 ± 23.24 | 147.0 [112.0–199.0] | 139.76 ± 26.48 | 131.0 [94.0–195.0] | |
| Test | [0–2,3][1–2,3] | [0,1–3] | |||
*α<0.05
aMann-Whitney U, bindependent sample-t, crepeated measures, dFriedman
Comparison of MA-II scores of patients during different stages
| MA-II | Experimental group ( | Control group ( | Test | ||
|---|---|---|---|---|---|
| Median [min–max] | Median [min–max] | ||||
| Preoperative (0) | 0.50 ± 1.28 | 0.5 [(− 2.8)–(2.5)] | 0.13 ± 0.124 | − 0.1 [(− 2.5)–(3.0)] | |
| 1st mount(1) | 1.01 ± 1.09 | 1.3 [(− 1.2)–(3.0)] | 0.70 ± 1.34 | 1.0 [(− 2.0)–(3.0)] | |
| 2nd month(2) | 1.47 ± 0.90 | 1.7 [(− 0.5)–(2.8)] | 1.17 ± 1.26 | 1.6 [(− 2.0)–(3.0)] | |
| 3rd month(3) | 1.72 ± 0.87 | 1.9 [(− 0.1)–(3.0)] | 1.32 ± 1.42 | 1.7 [(− 3.0)–(2.9)] | Z = − 0.773b |
| Test | [0–2,3][1–3] | [0–2,3][1–2,3] | |||
*α<0.05
aIndependent sample-t, bMann-Whitney U, crepeated measures, dFriedman
Comparison of body mass index (kg/m2) mean scores of patients during different stages
| BMI (kg/m2) | Experimental group ( | Control group ( | Test | ||
|---|---|---|---|---|---|
| Median [min–max] | Median [min–max] | ||||
| Preoperative(0) | 41.40 ± 3.62 | 41.2 [35.4–48.7] | 44.54 ± 5.34 | 42.7 [37.4–54.9] | Z = − 2.265a |
| 1st mount(1) | 36.66 ± 3.69 | 36.1 [29.9–45.2] | 40.36 ± 5.61 | 38.0 [33.9–52,8] | Z = − 1.318a |
| 2nd month(2) | 33.95 ± 3.75 | 34.1 [27.7–42.5] | 37.57 ± 5.42 | 34.5 [31.5–50.3] | |
| 3rd month(3) | 31.73 ± 3.68 | 31.6 [23.5–39.0] | 35.35 ± 5.39 | 32.9 [28.8–48.2] | |
| Test | [0–1,2,3][1–2,3][2–3] | [0–1,2,3][1–2,3][2–3] | |||
*α<0.05
aMann-Whitney U, brepeated measures, cFriedman